Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Blake Gilks

Showing results (31-40 of 383) with videos related to

Pageof 39
Sort By:
Histopathology|December 18, 2012
Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlatesAnanta Gurung, Tawny Hung, Jason Morin, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 1, 2019
Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular SubtypingNick Baniak, C Blake Gilks, John DeCoteau, et al.
Histopathology|August 26, 2011
Patterns of p53 immunoreactivity in endometrial carcinomas: 'all or nothing' staining is of importanceW Glenn McCluggage, Robert A Soslow, C Blake Gilks
Gynecologic Oncology Reports|June 13, 2018
Ovarian carcinoma histotype in Lynch syndromeC Blake Gilks, Blaise A Clarke, William D Foulkes
Histopathology|March 26, 2014
Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposalNaveena Singh, C Blake Gilks, Nafisa Wilkinson, et al.
The Journal of Pathology|December 28, 2020
Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosisJutta Huvila, Jennifer Pors, Emily F Thompson, et al.
Histopathology|February 3, 2015
Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneumNaveena Singh, C Blake Gilks, Nafisa Wilkinson, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 23, 2010
High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomesAbdulmohsen Alkushi, Martin Köbel, Steve E Kalloger, et al.
Fertility and Sterility|July 4, 2002
Cyclical expression of the DNA mismatch repair enzyme hMLH1 in normal endometriumJulie A Irving, Beverley Dupuis, Lily Wang, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 21, 2026
Coexistent Endometrial and Ovarian Carcinoma: Terminology, Clinicopathological Features, and Clinical SignificanceJutta Huvila, C Blake Gilks, Jessica N McAlpine, et al.
Pageof 39

Showing results (31-40 of 383) with videos related to

Sort By:
Pageof 39
Histopathology|December 18, 2012
Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlatesAnanta Gurung, Tawny Hung, Jason Morin, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 1, 2019
Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular SubtypingNick Baniak, C Blake Gilks, John DeCoteau, et al.
Histopathology|August 26, 2011
Patterns of p53 immunoreactivity in endometrial carcinomas: 'all or nothing' staining is of importanceW Glenn McCluggage, Robert A Soslow, C Blake Gilks
Gynecologic Oncology Reports|June 13, 2018
Ovarian carcinoma histotype in Lynch syndromeC Blake Gilks, Blaise A Clarke, William D Foulkes
Histopathology|March 26, 2014
Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposalNaveena Singh, C Blake Gilks, Nafisa Wilkinson, et al.
The Journal of Pathology|December 28, 2020
Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosisJutta Huvila, Jennifer Pors, Emily F Thompson, et al.
Histopathology|February 3, 2015
Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneumNaveena Singh, C Blake Gilks, Nafisa Wilkinson, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 23, 2010
High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomesAbdulmohsen Alkushi, Martin Köbel, Steve E Kalloger, et al.
Fertility and Sterility|July 4, 2002
Cyclical expression of the DNA mismatch repair enzyme hMLH1 in normal endometriumJulie A Irving, Beverley Dupuis, Lily Wang, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 21, 2026
Coexistent Endometrial and Ovarian Carcinoma: Terminology, Clinicopathological Features, and Clinical SignificanceJutta Huvila, C Blake Gilks, Jessica N McAlpine, et al.
Pageof 39